MetaADEDB 2.0 @ LMMD
Imatinib Mesylate
(KTUFNOKKBVMGRW-UHFFFAOYSA-N)
Structure
SMILES
CN1CCN(CC1)Cc1ccc(cc1)C(=O)Nc1ccc(c(c1)Nc1nccc(n1)c1cccnc1)C
Type(s)
Approved
ATC code(s)
L01XE01
Molecular Formula:
C29H31N7O
Molecular Weight:
493.603
Log P:
4.6121
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
2
TPSA:
86.28
CAS Number(s):
152459-95-5
Synonym(s)
1.
Imatinib Mesylate
2.
Alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide
3.
CGP 57148
4.
CGP-57148
5.
CGP57148B
6.
Gleevec
7.
Glivec
8.
Imatinib
9.
Imatinib Methanesulfonate
10.
ST 1571
11.
ST1571
12.
STI 571
13.
STI-571
14.
STI571
15.
CGP57148
16.
Mesylate, Imatinib
17.
Methanesulfonate, Imatinib
External Link(s)
MeSHD000068877
PubChem Compound5291
BindingDB13530
ChEBI45783
CHEMBLCHEMBL941
DrugBankDB00619
DrugCentral1423
IUPHAR/BPS Guide to PHARMACOLOGY5687
KEGGdr:D01441
dr:D08066
Therapeutic Target DatabaseD0AZ3C
D01UCI
ZINC19632618
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Malignant neoplasm progressionFAERS: 251
Canada Vigilance: 6
Canada Vigilance
OFFSIDES
US FAERS
2NauseaFAERS: 166
Canada Vigilance: 6
Canada Vigilance
OFFSIDES
SIDER
US FAERS
3Drug resistanceFAERS: 163
Canada Vigilance: 7
Canada Vigilance
OFFSIDES
US FAERS
4Drug ineffectiveFAERS: 129
Canada Vigilance: 14
Canada Vigilance
US FAERS
5FatigueFAERS: 107
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
6VomitingFAERS: 93
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
7ThrombocytopeniaFAERS: 79
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
8PancytopeniaFAERS: 76SIDER
US FAERS
9Disease ProgressionFAERS: 73
Canada Vigilance: 1
Canada Vigilance
US FAERS
10NeutropeniaFAERS: 63
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
11Abdominal PainFAERS: 62
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
SIDER
US FAERS
12PneumoniaFAERS: 62SIDER
US FAERS
13SepsisFAERS: 57
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
14treatment failureFAERS: 57
Canada Vigilance: 4
Canada Vigilance
US FAERS
15Product substitution issueFAERS: 56
Canada Vigilance: 10
Canada Vigilance
US FAERS
16MalaiseFAERS: 49SIDER
US FAERS
17HeadacheFAERS: 45
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
18InfectionFAERS: 45OFFSIDES
SIDER
US FAERS
19Toxicity to various agentsFAERS: 44
Canada Vigilance: 1
Canada Vigilance
US FAERS
20General physical health deteriorationFAERS: 42OFFSIDES
US FAERS
21ArthralgiaFAERS: 40
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
22MetastasisFAERS: 38US FAERS
23PruritusFAERS: 37SIDER
US FAERS
24AstheniaFAERS: 36SIDER
US FAERS
25PainFAERS: 36SIDER
US FAERS
26Gastric Antral Vascular EctasiaFAERS: 35
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
27MyalgiaFAERS: 35
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
28Product use in unapproved indicationFAERS: 32
Canada Vigilance: 4
Canada Vigilance
US FAERS
29MYELODYSPLASTIC SYNDROMEFAERS: 31US FAERS
30Weight decreasedFAERS: 30SIDER
US FAERS
31Cerebrovascular accidentFAERS: 29US FAERS
32Disease recurrenceFAERS: 29US FAERS
33SplenomegalyFAERS: 28US FAERS
34LeukopeniaFAERS: 27SIDER
US FAERS
35Abdominal discomfortFAERS: 25
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
36DizzinessFAERS: 25
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
37White blood cell count decreasedFAERS: 25SIDER
US FAERS
38AscitesFAERS: 24
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
39HaematotoxicityFAERS: 24US FAERS
40Maternal exposure during pregnancyFAERS: 24US FAERS
41Myocardial InfarctionFAERS: 24SIDER
US FAERS
42Septic ShockFAERS: 24US FAERS
43Therapy non-responderFAERS: 24
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
US FAERS
44Respiratory FailureFAERS: 23US FAERS
45Bone painFAERS: 21SIDER
US FAERS
46Exposure via fatherFAERS: 21US FAERS
47HypersensitivityFAERS: 21SIDER
US FAERS
48MyelofibrosisFAERS: 20US FAERS
49No adverse eventFAERS: 20US FAERS
50PseudoporphyriaFAERS: 20US FAERS
51AlopeciaFAERS: 19SIDER
US FAERS
52Drug level increasedFAERS: 19US FAERS
53Gene MutationFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
54LymphadenopathyFAERS: 19SIDER
US FAERS
55Philadelphia chromosome positiveFAERS: 19US FAERS
56SwellingFAERS: 19US FAERS
57Chest PainFAERS: 18SIDER
US FAERS
58Drug effect incompleteFAERS: 18US FAERS
59DyspepsiaFAERS: 18
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
60Back PainFAERS: 17SIDER
US FAERS
61ConstipationFAERS: 17SIDER
US FAERS
62Drug exposure during pregnancyFAERS: 17US FAERS
63Peripheral swellingFAERS: 17US FAERS
64Blood creatinine increasedFAERS: 16OFFSIDES
SIDER
US FAERS
65DehydrationFAERS: 16SIDER
US FAERS
66LeukocytosisFAERS: 16US FAERS
67Product physical issueFAERS: 16US FAERS
68Blood blisterFAERS: 15US FAERS
69Cerebral InfarctionFAERS: 15US FAERS
70HepatotoxicityFAERS: 15SIDER
US FAERS
71MalariaFAERS: 15US FAERS
72Pericardial effusionFAERS: 15
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
73Skin lesionFAERS: 15US FAERS
74Therapy cessationFAERS: 15US FAERS
75Dry skinFAERS: 14
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
76DysgeusiaFAERS: 14SIDER
US FAERS
77Febrile NeutropeniaFAERS: 14SIDER
US FAERS
78Joint swellingFAERS: 14SIDER
US FAERS
79Night sweatsFAERS: 14SIDER
US FAERS
80Peripheral arterial occlusive diseaseFAERS: 14US FAERS
81Stem cell transplantFAERS: 14OFFSIDES
US FAERS
82jaundiceFAERS: 14SIDER
US FAERS
83Alanine Aminotransferase IncreasedFAERS: 13OFFSIDES
SIDER
US FAERS
84BlindnessFAERS: 13US FAERS
85Ejection Fraction DecreasedFAERS: 13
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
86Growth retardationFAERS: 13SIDER
US FAERS
87Aspartate Aminotransferase IncreasedFAERS: 12SIDER
US FAERS
88Complications of transplant surgeryFAERS: 12US FAERS
89Concomitant disease progressionFAERS: 12OFFSIDES
US FAERS
90Low birth weight babyFAERS: 12US FAERS
91Rash erythematousFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
92Blood lactate dehydrogenase increasedFAERS: 11OFFSIDES
SIDER
US FAERS
93ChillsFAERS: 11SIDER
US FAERS
94ErythemaFAERS: 11
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
95Intestinal ObstructionFAERS: 11SIDER
US FAERS
96Musculoskeletal PainFAERS: 11SIDER
US FAERS
97Accidental exposure to productFAERS: 10US FAERS
98Acquired gene mutationFAERS: 10US FAERS
99Circumstance or information capable of leading to medication errorFAERS: 10US FAERS
100Cytogenetic analysis abnormalFAERS: 10
Canada Vigilance: 3
Canada Vigilance
US FAERS
101Gene mutation identification test positiveFAERS: 10US FAERS
102HepatomegalyFAERS: 10US FAERS
103PallorFAERS: 10US FAERS
104PancreatitisFAERS: 10SIDER
US FAERS
105Productive CoughFAERS: 10US FAERS
106ScabFAERS: 10OFFSIDES
US FAERS
107Skin ErosionFAERS: 10OFFSIDES
US FAERS
108Acute kidney injuryFAERS: 9US FAERS
109AgranulocytosisFAERS: 9SIDER
US FAERS
110Bone density decreasedFAERS: 9US FAERS
111CardiotoxicityFAERS: 9US FAERS
112EosinophiliaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
113Invasive Ductal Breast CarcinomaFAERS: 9US FAERS
114SomnolenceFAERS: 9
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
115Cardiac ArrestFAERS: 8SIDER
US FAERS
116Disease complicationFAERS: 8US FAERS
117Disseminated Intravascular CoagulationFAERS: 8OFFSIDES
US FAERS
118Feeling abnormalFAERS: 8SIDER
US FAERS
119HepatitisFAERS: 8SIDER
US FAERS
120Pulmonary EmbolismFAERS: 8US FAERS
121Therapy changeFAERS: 8US FAERS
122Transaminases increasedFAERS: 8OFFSIDES
US FAERS
123CachexiaFAERS: 7US FAERS
124Chest discomfortFAERS: 7US FAERS
125Concomitant disease aggravatedFAERS: 7OFFSIDES
US FAERS
126Diabetes MellitusFAERS: 7US FAERS
127Full blood count decreasedFAERS: 7US FAERS
128Gastrointestinal toxicityFAERS: 7US FAERS
129Hepatitis BFAERS: 7OFFSIDES
US FAERS
130InflammationFAERS: 7US FAERS
131Oropharyngeal painFAERS: 7SIDER
US FAERS
132Pancreatic carcinomaFAERS: 7US FAERS
133TuberculosisFAERS: 7US FAERS
134Visual ImpairmentFAERS: 7US FAERS
135AbasiaFAERS: 6OFFSIDES
US FAERS
136Adverse eventFAERS: 6US FAERS
137AnxietyFAERS: 6SIDER
US FAERS
138Atrial FibrillationFAERS: 6
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
139Blast cells presentFAERS: 6OFFSIDES
US FAERS
140Blood alkaline phosphatase increasedFAERS: 6OFFSIDES
SIDER
US FAERS
141Blood creatine phosphokinase increasedFAERS: 6OFFSIDES
SIDER
US FAERS
142Bone marrow depressionFAERS: 6SIDER
US FAERS
143BronchopneumoniaFAERS: 6US FAERS
144ChordomaFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
145CytopeniaFAERS: 6
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
146DermatitisFAERS: 6SIDER
US FAERS
147EpistaxisFAERS: 6SIDER
US FAERS
148Flank PainFAERS: 6US FAERS
149Hepatitis CFAERS: 6US FAERS
150HydronephrosisFAERS: 6OFFSIDES
US FAERS
151NasopharyngitisFAERS: 6SIDER
US FAERS
152PalpitationsFAERS: 6SIDER
US FAERS
153Pneumatosis intestinalisFAERS: 6US FAERS
154Product dose omissionFAERS: 6US FAERS
155Product storage errorFAERS: 6US FAERS
156Product use issueFAERS: 6US FAERS
157Skin necrosisFAERS: 6US FAERS
158StomatitisFAERS: 6SIDER
US FAERS
159Urinary tract infectionFAERS: 6SIDER
US FAERS
160AmnesiaFAERS: 5OFFSIDES
US FAERS
161ArthritisFAERS: 5SIDER
US FAERS
162Benign NeoplasmFAERS: 5US FAERS
163Blood urea increasedFAERS: 5OFFSIDES
US FAERS
164Bone marrow necrosisFAERS: 5US FAERS
165Bone marrow reticulin fibrosisFAERS: 5US FAERS
166Coronary Artery DiseaseFAERS: 5US FAERS
167CraniosynostosisFAERS: 5US FAERS
168DiplopiaFAERS: 5US FAERS
169Drug dose omissionFAERS: 5US FAERS
170Drug withdrawal syndromeFAERS: 5US FAERS
171DysarthriaFAERS: 5US FAERS
172EcchymosisFAERS: 5SIDER
US FAERS
173EructationFAERS: 5SIDER
US FAERS
174Graft versus host disease in skinFAERS: 5US FAERS
175HepatosplenomegalyFAERS: 5US FAERS
176HypertrichosisFAERS: 5US FAERS
177HypotensionFAERS: 5
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
178HypoxiaFAERS: 5OFFSIDES
SIDER
US FAERS
179KeratitisFAERS: 5US FAERS
180LethargyFAERS: 5SIDER
US FAERS
181Neutrophil count decreasedFAERS: 5OFFSIDES
SIDER
US FAERS
182NoduleFAERS: 5US FAERS
183OnychoclasisFAERS: 5SIDER
US FAERS
184PeritonitisFAERS: 5US FAERS
185Post procedural complicationFAERS: 5US FAERS
186PregnancyFAERS: 5US FAERS
187PsoriasisFAERS: 5OFFSIDES
SIDER
US FAERS
188SclerodermaFAERS: 5US FAERS
189ShockFAERS: 5SIDER
US FAERS
190Transmission of drug via semenFAERS: 5US FAERS
191TremorFAERS: 5SIDER
US FAERS
192VertigoFAERS: 5SIDER
US FAERS
193Acute myocardial infarctionFAERS: 4US FAERS
194Angina PectorisFAERS: 4SIDER
US FAERS
195Autoimmune hepatitisFAERS: 4US FAERS
196Burning sensationFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
197CholelithiasisFAERS: 4US FAERS
198CholestasisFAERS: 4US FAERS
199DeafnessFAERS: 4SIDER
US FAERS
200Dental cariesFAERS: 4OFFSIDES
US FAERS
201Depressed Level of ConsciousnessFAERS: 4OFFSIDES
US FAERS
202Hepatic EncephalopathyFAERS: 4US FAERS
203Hypertensive crisisFAERS: 4US FAERS
204ImmunosuppressionFAERS: 4US FAERS
205Incorrect product storageFAERS: 4US FAERS
206Liver AbscessFAERS: 4OFFSIDES
US FAERS
207MeningiomaFAERS: 4US FAERS
208MyositisFAERS: 4US FAERS
209NeuroblastomaFAERS: 4US FAERS
210Neutropenic sepsisFAERS: 4US FAERS
211Optic NeuritisFAERS: 4SIDER
US FAERS
212Pain of skinFAERS: 4US FAERS
213Product quality issueFAERS: 4US FAERS
214Pyogenic granulomaFAERS: 4US FAERS
215Renal Cell CarcinomaFAERS: 4US FAERS
216Respiratory distressFAERS: 4US FAERS
217Retroperitoneal fibrosisFAERS: 4US FAERS
218SciaticaFAERS: 4SIDER
US FAERS
219Sudden Cardiac DeathFAERS: 4US FAERS
220Sudden deathFAERS: 4US FAERS
221Swelling of eyelidFAERS: 4US FAERS
222Unevaluable eventFAERS: 4US FAERS
223Ureteral stent insertionFAERS: 4US FAERS
224UrticariaFAERS: 4SIDER
US FAERS
225Wrong technique in product usage processFAERS: 4US FAERS
226nervous system disorderFAERS: 4SIDER
US FAERS
227AbscessFAERS: 3US FAERS
228Acute Coronary SyndromeFAERS: 3SIDER
US FAERS
229AlveolitisFAERS: 3OFFSIDES
US FAERS
230AphagiaFAERS: 3US FAERS
231AsthmaFAERS: 3US FAERS
232Autoantibody positiveFAERS: 3US FAERS
233Basal cell carcinomaFAERS: 3US FAERS
234Blast cell proliferationFAERS: 3US FAERS
235Blood albumin decreasedFAERS: 3US FAERS
236Blood count abnormalFAERS: 3US FAERS
237Blood iron decreasedFAERS: 3US FAERS
238Blood parathyroid hormone increasedFAERS: 3US FAERS
239Blood phosphorus decreasedFAERS: 3US FAERS
240Blood potassium decreasedFAERS: 3US FAERS
241Brain natriuretic peptide increasedFAERS: 3US FAERS
242CardiomegalyFAERS: 3US FAERS
243CataractFAERS: 3SIDER
US FAERS
244CholangiocarcinomaFAERS: 3US FAERS
245CholangitisFAERS: 3US FAERS
246ConjunctivitisFAERS: 3SIDER
US FAERS
247Diffuse Large B-Cell LymphomaFAERS: 3US FAERS
248DiscomfortFAERS: 3SIDER
US FAERS
249Dropped head syndromeFAERS: 3US FAERS
250Drug administration errorFAERS: 3US FAERS
251Electrolyte imbalanceFAERS: 3US FAERS
252EmbolismFAERS: 3OFFSIDES
SIDER
US FAERS
253Epstein-Barr virus associated lymphoproliferative disorderFAERS: 3US FAERS
254Exfoliative rashFAERS: 3US FAERS
255Eye irritationFAERS: 3SIDER
US FAERS
256Eye painFAERS: 3SIDER
US FAERS
257Feeling ColdFAERS: 3US FAERS
258FlatulenceFAERS: 3SIDER
US FAERS
259FlushingFAERS: 3SIDER
US FAERS
260GastrectomyFAERS: 3OFFSIDES
US FAERS
261GastritisFAERS: 3SIDER
US FAERS
262General physical condition abnormalFAERS: 3US FAERS
263General symptomFAERS: 3US FAERS
264Head discomfortFAERS: 3US FAERS
265Hyperemesis GravidarumFAERS: 3US FAERS
266HypophagiaFAERS: 3US FAERS
267HypothyroidismFAERS: 3US FAERS
268IleusFAERS: 3SIDER
US FAERS
269Iron deficiencyFAERS: 3US FAERS
270Joint stiffnessFAERS: 3US FAERS
271LacerationFAERS: 3US FAERS
272Limb discomfortFAERS: 3OFFSIDES
US FAERS
273Lipase increasedFAERS: 3US FAERS
274Lower respiratory tract infectionFAERS: 3SIDER
US FAERS
275Memory impairmentFAERS: 3SIDER
US FAERS
276Metabolic acidosisFAERS: 3US FAERS
277Mood swingsFAERS: 3US FAERS
278Myasthenia GravisFAERS: 3US FAERS
279NecrosisFAERS: 3SIDER
US FAERS
280Nephrotic SyndromeFAERS: 3US FAERS
281Oncologic complicationFAERS: 3US FAERS
282Oral candidiasisFAERS: 3US FAERS
283ParakeratosisFAERS: 3US FAERS
284Philadelphia chromosome negativeFAERS: 3US FAERS
285PneumonitisFAERS: 3US FAERS
286PneumothoraxFAERS: 3US FAERS
287PolyneuropathyFAERS: 3US FAERS
288Pulmonary EosinophiliaFAERS: 3US FAERS
289Pulmonary FibrosisFAERS: 3SIDER
US FAERS
290Pyoderma GangrenosumFAERS: 3US FAERS
291Retinal Vascular DisorderFAERS: 3US FAERS
292Skin reactionFAERS: 3US FAERS
293Skin toxicityFAERS: 3SIDER
US FAERS
294StillbirthFAERS: 3US FAERS
295TachycardiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
296ThrombocytosisFAERS: 3SIDER
US FAERS
297UlcerFAERS: 3SIDER
US FAERS
298WheezingFAERS: 3US FAERS
299Abdominal AbscessFAERS: 2US FAERS
300ActinomycosisFAERS: 2US FAERS
301Activities of daily living impairedFAERS: 2US FAERS
302Acute respiratory failureFAERS: 2SIDER
US FAERS
303Altered state of consciousnessFAERS: 2US FAERS
304Amyotrophic Lateral SclerosisFAERS: 2US FAERS
305Anal FissureFAERS: 2US FAERS
306AngioedemaFAERS: 2OFFSIDES
SIDER
US FAERS
307AnosmiaFAERS: 2US FAERS
308AphasiaFAERS: 2US FAERS
309AzoospermiaFAERS: 2US FAERS
310BRAF gene mutationFAERS: 2US FAERS
311Bacterial sepsisFAERS: 2US FAERS
312Benign Prostatic HyperplasiaFAERS: 2US FAERS
313Biopsy bone marrow abnormalFAERS: 2OFFSIDES
US FAERS
314Bladder discomfortFAERS: 2US FAERS
315Blood creatine increasedFAERS: 2US FAERS
316Blood follicle stimulating hormone increasedFAERS: 2US FAERS
317Blood testosterone decreasedFAERS: 2US FAERS
318Blood testosterone increasedFAERS: 2US FAERS
319Blood thyroid stimulating hormone increasedFAERS: 2US FAERS
320Bone formation decreasedFAERS: 2US FAERS
321Bone marrow harvest failureFAERS: 2US FAERS
322Bone marrow toxicityFAERS: 2US FAERS
323Bronchopulmonary AspergillosisFAERS: 2US FAERS
324Cell DeathFAERS: 2US FAERS
325Cell marker decreasedFAERS: 2US FAERS
326CholecystitisFAERS: 2US FAERS
327ClinodactylyFAERS: 2US FAERS
328ColitisFAERS: 2SIDER
US FAERS
329Completed SuicideFAERS: 2US FAERS
330Congenital HydrocephalusFAERS: 2US FAERS
331CraniectomyFAERS: 2US FAERS
332Cytomegalovirus test positiveFAERS: 2US FAERS
333Decreased immune responsivenessFAERS: 2US FAERS
334DeliriumFAERS: 2US FAERS
335Dengue FeverFAERS: 2OFFSIDES
US FAERS
336Depressed moodFAERS: 2OFFSIDES
US FAERS
337Device related infectionFAERS: 2US FAERS
338DextrocardiaFAERS: 2US FAERS
339Diastolic dysfunctionFAERS: 2US FAERS
340Drug prescribing errorFAERS: 2US FAERS
341Drug toxicityFAERS: 2US FAERS
342DysuriaFAERS: 2US FAERS
343EclampsiaFAERS: 2US FAERS
344Economic problemFAERS: 2US FAERS
345EczemaFAERS: 2SIDER
US FAERS
346EmpyemaFAERS: 2US FAERS
347EpilepsyFAERS: 2US FAERS
348Erectile dysfunctionFAERS: 2SIDER
US FAERS
349Erythema MultiformeFAERS: 2SIDER
US FAERS
350Escherichia infectionFAERS: 2US FAERS
351Eyelid margin crustingFAERS: 2US FAERS
352Failure to ThriveFAERS: 2OFFSIDES
US FAERS
353FasciitisFAERS: 2US FAERS
354FibrosisFAERS: 2US FAERS
355Gastric pH decreasedFAERS: 2US FAERS
356Gastrointestinal PainFAERS: 2SIDER
US FAERS
357Gastrointestinal angiectasiaFAERS: 2US FAERS
358Gastrointestinal erosionFAERS: 2US FAERS
359Genital abscessFAERS: 2US FAERS
360GoutFAERS: 2SIDER
US FAERS
361Graft versus host disease in lungFAERS: 2US FAERS
362Growth failureFAERS: 2US FAERS
363Guillain-Barre SyndromeFAERS: 2US FAERS
364HemiplegiaFAERS: 2US FAERS
365Hepatic necrosisFAERS: 2SIDER
US FAERS
366Hip surgeryFAERS: 2US FAERS
367Histiocytosis haematophagicFAERS: 2OFFSIDES
US FAERS
368HungerFAERS: 2US FAERS
369HyperreflexiaFAERS: 2US FAERS
370HypersomniaFAERS: 2US FAERS
371HyperthyroidismFAERS: 2US FAERS
372Immune thrombocytopenic purpuraFAERS: 2US FAERS
373Impaired work abilityFAERS: 2US FAERS
374Incorrect dose administeredFAERS: 2US FAERS
375InfarctionFAERS: 2US FAERS
376InfluenzaFAERS: 2SIDER
US FAERS
377Insurance issueFAERS: 2US FAERS
378Intramedullary rod insertionFAERS: 2US FAERS
379Lactose IntoleranceFAERS: 2OFFSIDES
US FAERS
380Lichen PlanusFAERS: 2SIDER
US FAERS
381Lip swellingFAERS: 2US FAERS
382Live BirthFAERS: 2US FAERS
383LymphadenitisFAERS: 2US FAERS
384MalabsorptionFAERS: 2US FAERS
385Malignant tumour excisionFAERS: 2US FAERS
386Maternal exposure before pregnancyFAERS: 2US FAERS
387Metastases to pelvisFAERS: 2US FAERS
388Necrotising myositisFAERS: 2US FAERS
389Osteocalcin decreasedFAERS: 2US FAERS
390OsteomyelitisFAERS: 2US FAERS
391Pancreatic enzymes increasedFAERS: 2US FAERS
392PapuleFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
393Peripheral artery occlusionFAERS: 2US FAERS
394PlasmacytomaFAERS: 2US FAERS
395Pleurocutaneous fistulaFAERS: 2US FAERS
396PriapismFAERS: 2US FAERS
397Product dispensing errorFAERS: 2US FAERS
398Product taste abnormalFAERS: 2US FAERS
399ProteinuriaFAERS: 2US FAERS
400Pseudomonal sepsisFAERS: 2US FAERS
401Pulmonary congestionFAERS: 2OFFSIDES
US FAERS
402Pulmonary toxicityFAERS: 2US FAERS
403Purulent dischargeFAERS: 2US FAERS
404PyelonephritisFAERS: 2OFFSIDES
US FAERS
405PyomyositisFAERS: 2US FAERS
406Quality of life decreasedFAERS: 2US FAERS
407RalesFAERS: 2OFFSIDES
US FAERS
408Refractory cancerFAERS: 2US FAERS
409Renal ColicFAERS: 2US FAERS
410Renal cancer metastaticFAERS: 2US FAERS
411Renal painFAERS: 2SIDER
US FAERS
412RestlessnessFAERS: 2US FAERS
413Restrictive cardiomyopathyFAERS: 2US FAERS
414Rheumatoid ArthritisFAERS: 2US FAERS
415RosaceaFAERS: 2US FAERS
416Scedosporium infectionFAERS: 2US FAERS
417Secretion dischargeFAERS: 2US FAERS
418SinusitisFAERS: 2SIDER
US FAERS
419Skin UlcerFAERS: 2US FAERS
420Skin lacerationFAERS: 2US FAERS
421Skin noduleFAERS: 2US FAERS
422Skin tightnessFAERS: 2US FAERS
423SluggishnessFAERS: 2US FAERS
424Sodium retentionFAERS: 2US FAERS
425Spina Bifida OccultaFAERS: 2US FAERS
426Splenic RuptureFAERS: 2US FAERS
427Squamous cell carcinoma of lungFAERS: 2US FAERS
428Suicide attemptFAERS: 2US FAERS
429Suture related complicationFAERS: 2US FAERS
430SyncopeFAERS: 2SIDER
US FAERS
431Synovial CystFAERS: 2US FAERS
432Therapy partial responderFAERS: 2US FAERS
433ThrombosisFAERS: 2SIDER
US FAERS
434Tooth LossFAERS: 2US FAERS
435Transfusion related complicationFAERS: 2US FAERS
436Urinary IncontinenceFAERS: 2US FAERS
437Uterine CancerFAERS: 2US FAERS
438Ventricular hypertrophyFAERS: 2US FAERS
439VitiligoFAERS: 2US FAERS
440Vitreous DetachmentFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
441neurofibromaFAERS: 2US FAERS
442ATRIAL ENLARGEMENTFAERS: 1US FAERS
443Accidental underdoseFAERS: 1US FAERS
444Acid fast bacilli infectionFAERS: 1US FAERS
445AcneFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
446Acquired Immunodeficiency SyndromeFAERS: 1US FAERS
447Acquired hydroceleFAERS: 1US FAERS
448Acute prerenal failureFAERS: 1US FAERS
449AdenocarcinomaFAERS: 1US FAERS
450AgeusiaFAERS: 1US FAERS
451AgitationFAERS: 1US FAERS
452AgraphiaFAERS: 1US FAERS
453Alanine aminotransferase abnormalFAERS: 1US FAERS
454AlbinismFAERS: 1US FAERS
455AlbuminuriaFAERS: 1US FAERS
456Allogenic bone marrow transplantation therapyFAERS: 1OFFSIDES
US FAERS
457Alpha 2 globulin increasedFAERS: 1US FAERS
458Amylase increasedFAERS: 1SIDER
US FAERS
459Anal FistulaFAERS: 1US FAERS
460Anal abscessFAERS: 1OFFSIDES
US FAERS
461Anastomotic LeakFAERS: 1US FAERS
462AngerFAERS: 1US FAERS
463Angioimmunoblastic T-cell lymphoma recurrentFAERS: 1US FAERS
464AnisocytosisFAERS: 1US FAERS
465AnorexiaFAERS: 1OFFSIDES
SIDER
US FAERS
466Antibody test abnormalFAERS: 1US FAERS
467Aortic AneurysmFAERS: 1US FAERS
468Aortic RuptureFAERS: 1US FAERS
469AppendicitisFAERS: 1US FAERS
470AsphyxiaFAERS: 1OFFSIDES
US FAERS
471AstrocytomaFAERS: 1US FAERS
472AtaxiaFAERS: 1US FAERS
473Atrial FlutterFAERS: 1OFFSIDES
US FAERS
474Atypical pneumoniaFAERS: 1US FAERS
475B-cell small lymphocytic lymphoma stage IIIFAERS: 1US FAERS
476Basilar Artery StenosisFAERS: 1US FAERS
477BedriddenFAERS: 1US FAERS
478BicytopeniaFAERS: 1US FAERS
479Biliary cirrhosisFAERS: 1US FAERS
480Biliary dilatationFAERS: 1OFFSIDES
US FAERS
481Bladder adenocarcinoma stage unspecifiedFAERS: 1US FAERS
482BlepharochalasisFAERS: 1US FAERS
483Blood bilirubin abnormalFAERS: 1OFFSIDES
US FAERS
484Blood fibrinogen increasedFAERS: 1US FAERS
485Blood glucagon decreasedFAERS: 1US FAERS
486Blood glucose decreasedFAERS: 1US FAERS
487Blood glucose increasedFAERS: 1US FAERS
488Blood immunoglobulin G decreasedFAERS: 1US FAERS
489Blood immunoglobulin G increasedFAERS: 1US FAERS
490Blood potassium increasedFAERS: 1US FAERS
491Blood pressure fluctuationFAERS: 1US FAERS
492Blood pressure immeasurableFAERS: 1US FAERS
493Blood testosterone abnormalFAERS: 1US FAERS
494Blood urea abnormalFAERS: 1US FAERS
495Blood urine presentFAERS: 1OFFSIDES
US FAERS
496Bone erosionFAERS: 1US FAERS
497Bone infarctionFAERS: 1OFFSIDES
US FAERS
498Bone lesionFAERS: 1US FAERS
499Bowel movement irregularityFAERS: 1US FAERS
500BradycardiaFAERS: 1US FAERS
501Brain DeathFAERS: 1US FAERS
502Breakthrough PainFAERS: 1US FAERS
503Breech PresentationFAERS: 1US FAERS
504BronchitisFAERS: 1OFFSIDES
US FAERS
505Bronchoalveolar LavageFAERS: 1OFFSIDES
US FAERS
506C-kit gene mutationFAERS: 1US FAERS
507CalcinosisFAERS: 1US FAERS
508Cancer PainFAERS: 1US FAERS
509Cardiac TamponadeFAERS: 1SIDER
US FAERS
510Cardiac ventricular thrombosisFAERS: 1US FAERS
511Cardio-respiratory distressFAERS: 1US FAERS
512Cardiomyopathy neonatalFAERS: 1US FAERS
513Catheter sepsisFAERS: 1US FAERS
514CellulitisFAERS: 1SIDER
US FAERS
515Cerebral PalsyFAERS: 1US FAERS
516Cerebral cystFAERS: 1US FAERS
517Cerebral decompressionFAERS: 1US FAERS
518Cerebral ventricle dilatationFAERS: 1US FAERS
519Change in sustained attentionFAERS: 1US FAERS
520Chest wall painFAERS: 1US FAERS
521Cholecystitis infectiveFAERS: 1US FAERS
522ChoroiditisFAERS: 1US FAERS
523ChromaturiaFAERS: 1US FAERS
524Chromosomal mutationFAERS: 1US FAERS
525Chronic graft versus host disease in skinFAERS: 1US FAERS
526ChylothoraxFAERS: 1US FAERS
527Clonal EvolutionFAERS: 1US FAERS
528Clostridium colitisFAERS: 1US FAERS
529Cold sweatFAERS: 1OFFSIDES
US FAERS
530Complications of bone marrow transplantFAERS: 1US FAERS
531Congenital HypothyroidismFAERS: 1US FAERS
532Congenital diaphragmatic herniaFAERS: 1US FAERS
533Counterfeit product administeredFAERS: 1US FAERS
534CraniotomyFAERS: 1US FAERS
535Cutis LaxaFAERS: 1US FAERS
536CyanosisFAERS: 1US FAERS
537CystFAERS: 1SIDER
US FAERS
538Deep Vein ThrombosisFAERS: 1US FAERS
539DementiaFAERS: 1US FAERS
540Dermatitis acneiformFAERS: 1US FAERS
541DermatofibrosarcomaFAERS: 1US FAERS
542Device related sepsisFAERS: 1US FAERS
543Diabetes mellitus inadequate controlFAERS: 1US FAERS
544Diabetic RetinopathyFAERS: 1US FAERS
545Dieulafoy's vascular malformationFAERS: 1US FAERS
546Diffuse alveolar damageFAERS: 1US FAERS
547DiplegiaFAERS: 1US FAERS
548DisorientationFAERS: 1US FAERS
549Drug DependenceFAERS: 1US FAERS
550Drug dispensing errorFAERS: 1US FAERS
551Drug exposure before pregnancyFAERS: 1US FAERS
552Drug ineffective for unapproved indicationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
553Drug level decreasedFAERS: 1US FAERS
554Drug-disease interactionFAERS: 1US FAERS
555Duodenal perforationFAERS: 1US FAERS
556DuodenitisFAERS: 1US FAERS
557DyspareuniaFAERS: 1US FAERS
558DysphoniaFAERS: 1US FAERS
559Dystrophic calcificationFAERS: 1US FAERS
560Early satietyFAERS: 1US FAERS
561Echography abnormalFAERS: 1US FAERS
562Ectopic kidneyFAERS: 1US FAERS
563EctropionFAERS: 1US FAERS
564Electrocardiogram abnormalFAERS: 1US FAERS
565Electroencephalogram abnormalFAERS: 1US FAERS
566Emotional distressFAERS: 1US FAERS
567Endocarditis fibroplasticaFAERS: 1US FAERS
568Endometrial Stromal SarcomaFAERS: 1US FAERS
569Endometrial adenocarcinomaFAERS: 1US FAERS
570Endoscopy abnormalFAERS: 1OFFSIDES
US FAERS
571EnteritisFAERS: 1US FAERS
572EnterocolitisFAERS: 1US FAERS
573Eosinophil percentage increasedFAERS: 1OFFSIDES
US FAERS
574Eosinophilic PneumoniaFAERS: 1US FAERS
575EpitheliomaFAERS: 1US FAERS
576ErysipelasFAERS: 1US FAERS
577Erythroblast count increasedFAERS: 1US FAERS
578ErythromelalgiaFAERS: 1US FAERS
579Escherichia urinary tract infectionFAERS: 1US FAERS
580ExophthalmosFAERS: 1US FAERS
581Eye inflammationFAERS: 1US FAERS
582Facial ParesisFAERS: 1US FAERS
583Fibrin D dimer increasedFAERS: 1US FAERS
584FibromyalgiaFAERS: 1US FAERS
585FilariasisFAERS: 1US FAERS
586Focal Nodular HyperplasiaFAERS: 1US FAERS
587Full blood count abnormalFAERS: 1US FAERS
588Full blood count increasedFAERS: 1US FAERS
589Gallop rhythm presentFAERS: 1US FAERS
590Gamma-Glutamyltransferase IncreasedFAERS: 1OFFSIDES
US FAERS
591Gastric mucosal lesionFAERS: 1US FAERS
592Gastrointestinal carcinomaFAERS: 1US FAERS
593Gastrointestinal disorder postoperativeFAERS: 1US FAERS
594Gastrointestinal infectionFAERS: 1US FAERS
595Gastrointestinal perforationFAERS: 1SIDER
US FAERS
596Gastrointestinal stoma complicationFAERS: 1US FAERS
597Gastrointestinal stromal cancerFAERS: 1US FAERS
598Gastrointestinal wall thinningFAERS: 1US FAERS
599Gelatinous transformation of the bone marrowFAERS: 1US FAERS
600Gestational DiabetesFAERS: 1US FAERS
601Glioblastoma MultiformeFAERS: 1US FAERS
602GlioblastomaFAERS: 1US FAERS
603GlomerulonephritisFAERS: 1US FAERS
604HER-2 positive breast cancerFAERS: 1US FAERS
605HemiparesisFAERS: 1US FAERS
606Hepatic congestionFAERS: 1US FAERS
607Hepatitis B DNA increasedFAERS: 1US FAERS
608HerniaFAERS: 1US FAERS
609Hilar lymphadenopathyFAERS: 1US FAERS
610HistiocytosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
611Homans' sign positiveFAERS: 1US FAERS
612HordeolumFAERS: 1US FAERS
613Hormone level abnormalFAERS: 1US FAERS
614Hospice CareFAERS: 1US FAERS
615Human herpesvirus 8 infectionFAERS: 1US FAERS
616HydrocephalusFAERS: 1US FAERS
617HyperaldosteronismFAERS: 1US FAERS
618HyperleukocytosisFAERS: 1US FAERS
619HyperplasiaFAERS: 1US FAERS
620HyperpyrexiaFAERS: 1US FAERS
621HypertransaminasaemiaFAERS: 1US FAERS
622Hypertrophic osteoarthropathyFAERS: 1US FAERS
623HypertrophyFAERS: 1US FAERS
624Hyperviscosity syndromeFAERS: 1US FAERS
625HypokinesiaFAERS: 1US FAERS
626HypospadiasFAERS: 1US FAERS
627HypoventilationFAERS: 1US FAERS
628Idiosyncratic drug reactionFAERS: 1US FAERS
629Immature respiratory systemFAERS: 1US FAERS
630Inability to afford medicationFAERS: 1US FAERS
631Inappropriate schedule of drug administrationFAERS: 1US FAERS
632Incorrect route of drug administrationFAERS: 1US FAERS
633Infectious pleural effusionFAERS: 1US FAERS
634InfertilityFAERS: 1US FAERS
635Injection site painFAERS: 1US FAERS
636Insulin C-peptide decreasedFAERS: 1US FAERS
637Insulin-like growth factor decreasedFAERS: 1US FAERS
638Insulin-like growth factor increasedFAERS: 1OFFSIDES
US FAERS
639Intentional product use issueFAERS: 1US FAERS
640Intermittent ClaudicationFAERS: 1US FAERS
641Intestinal adenocarcinomaFAERS: 1US FAERS
642Irritable Bowel SyndromeFAERS: 1US FAERS
643Jejunal ulcerFAERS: 1US FAERS
644Joint Range of Motion DecreasedFAERS: 1US FAERS
645LagophthalmosFAERS: 1US FAERS
646Large cell lung cancer stage IIIFAERS: 1US FAERS
647Laryngeal Squamous Cell CarcinomaFAERS: 1US FAERS
648Laryngeal discomfortFAERS: 1US FAERS
649Leukaemic infiltration brainFAERS: 1US FAERS
650Leukocytoclastic vasculitisFAERS: 1SIDER
US FAERS
651LeukostasisFAERS: 1US FAERS
652Ligament injuryFAERS: 1US FAERS
653Light chain analysis increasedFAERS: 1US FAERS
654Lip exfoliationFAERS: 1US FAERS
655Liver transplant rejectionFAERS: 1US FAERS
656Lobar PneumoniaFAERS: 1US FAERS
657Localised intraabdominal fluid collectionFAERS: 1US FAERS
658Loss of personal independence in daily activitiesFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
659Low Cardiac Output SyndromeFAERS: 1US FAERS
660Low set earsFAERS: 1US FAERS
661Lumbar herniaFAERS: 1US FAERS
662Lumbar puncture abnormalFAERS: 1US FAERS
663Lung AbscessFAERS: 1OFFSIDES
US FAERS
664Lung consolidationFAERS: 1US FAERS
665Lupus-like syndromeFAERS: 1US FAERS
666Lymphocyte count abnormalFAERS: 1US FAERS
667Lymphocyte count decreasedFAERS: 1OFFSIDES
US FAERS
668Lymphocyte count increasedFAERS: 1US FAERS
669Lymphocytic infiltrationFAERS: 1US FAERS
670LymphocytosisFAERS: 1US FAERS
671LymphomaFAERS: 1US FAERS
672LymphopeniaFAERS: 1SIDER
US FAERS
673MaculeFAERS: 1US FAERS
674Malignant ascitesFAERS: 1US FAERS
675MalnutritionFAERS: 1SIDER
US FAERS
676Mantle cell lymphomaFAERS: 1US FAERS
677MarasmusFAERS: 1US FAERS
678Maternal exposure during deliveryFAERS: 1US FAERS
679Mediastinal massFAERS: 1US FAERS
680MediastinitisFAERS: 1US FAERS
681Medication residue presentFAERS: 1US FAERS
682Metastases to abdominal wallFAERS: 1US FAERS
683Metastases to adrenalsFAERS: 1US FAERS
684Metastatic NeoplasmFAERS: 1US FAERS
685MicrocytosisFAERS: 1US FAERS
686Middle insomniaFAERS: 1US FAERS
687Monocyte count increasedFAERS: 1US FAERS
688MonocytosisFAERS: 1US FAERS
689Mononeuropathy MultiplexFAERS: 1US FAERS
690MonoplegiaFAERS: 1US FAERS
691Mouth swellingFAERS: 1US FAERS
692Mucinous adenocarcinoma of appendixFAERS: 1US FAERS
693Mucosal erosionFAERS: 1US FAERS
694Mucosal pigmentationFAERS: 1US FAERS
695MultimorbidityFAERS: 1US FAERS
696Multiple MyelomaFAERS: 1US FAERS
697Muscle SpasticityFAERS: 1US FAERS
698Muscle tightnessFAERS: 1US FAERS
699Musculoskeletal discomfortFAERS: 1SIDER
US FAERS
700Musculoskeletal stiffnessFAERS: 1OFFSIDES
SIDER
US FAERS
701Mycosis FungoidesFAERS: 1US FAERS
702MydriasisFAERS: 1US FAERS
703Myocardial necrosis marker increasedFAERS: 1US FAERS
704MyocarditisFAERS: 1US FAERS
705MyofascitisFAERS: 1US FAERS
706MyopathyFAERS: 1SIDER
US FAERS
707Nasal PolypsFAERS: 1US FAERS
708Nasal inflammationFAERS: 1US FAERS
709Nephrogenic Systemic FibrosisFAERS: 1US FAERS
710NephrolithiasisFAERS: 1US FAERS
711NephrosclerosisFAERS: 1US FAERS
712Nerve Root CompressionFAERS: 1US FAERS
713NervousnessFAERS: 1US FAERS
714NeurodermatitisFAERS: 1OFFSIDES
US FAERS
715NeurofibrosarcomaFAERS: 1US FAERS
716Neutropenic infectionFAERS: 1US FAERS
717Norepinephrine increasedFAERS: 1US FAERS
718Ocular icterusFAERS: 1US FAERS
719OliguriaFAERS: 1OFFSIDES
US FAERS
720Oral fungal infectionFAERS: 1US FAERS
721Orbital cystFAERS: 1US FAERS
722Osteonecrosis of JawFAERS: 1US FAERS
723OsteoporosisFAERS: 1US FAERS
724OsteosclerosisFAERS: 1US FAERS
725Otitis MediaFAERS: 1US FAERS
726Ovarian adenomaFAERS: 1US FAERS
727Ovarian failureFAERS: 1US FAERS
728OverdoseFAERS: 1US FAERS
729ParacentesisFAERS: 1OFFSIDES
US FAERS
730Paraneoplastic dermatomyositisFAERS: 1US FAERS
731Parathyroid hormone-related protein increasedFAERS: 1US FAERS
732ParesisFAERS: 1US FAERS
733ParophthalmiaFAERS: 1US FAERS
734Patent ductus arteriosusFAERS: 1US FAERS
735Pelvic massFAERS: 1OFFSIDES
US FAERS
736Perforated ulcerFAERS: 1US FAERS
737Performance status decreasedFAERS: 1OFFSIDES
US FAERS
738PericarditisFAERS: 1SIDER
US FAERS
739Periorbital swellingFAERS: 1US FAERS
740Peripheral motor neuropathyFAERS: 1US FAERS
741Peritoneal lesionFAERS: 1US FAERS
742Peritonsillar AbscessFAERS: 1OFFSIDES
US FAERS
743PetechiaeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
744Pharyngeal swellingFAERS: 1US FAERS
745PharyngitisFAERS: 1SIDER
US FAERS
746PhimosisFAERS: 1US FAERS
747PhlebitisFAERS: 1US FAERS
748Platelet dysfunctionFAERS: 1US FAERS
749PleurectomyFAERS: 1US FAERS
750PleurisyFAERS: 1US FAERS
751PneumoperitoneumFAERS: 1US FAERS
752PoisoningFAERS: 1US FAERS
753Poor quality sleepFAERS: 1US FAERS
754Porphyria non-acuteFAERS: 1US FAERS
755Porphyrins urine increasedFAERS: 1US FAERS
756Posterior reversible encephalopathy syndromeFAERS: 1US FAERS
757Premature baby deathFAERS: 1US FAERS
758Prerenal failureFAERS: 1US FAERS
759Procalcitonin increasedFAERS: 1US FAERS
760Procedural nauseaFAERS: 1US FAERS
761Product coating issueFAERS: 1US FAERS
762Product distribution issueFAERS: 1US FAERS
763Product solubility abnormalFAERS: 1US FAERS
764Product use complaintFAERS: 1US FAERS
765ProstatectomyFAERS: 1US FAERS
766Prostatic AdenomaFAERS: 1US FAERS
767Prostatic calcificationFAERS: 1US FAERS
768Protein urine presentFAERS: 1US FAERS
769Prothrombin time ratio decreasedFAERS: 1US FAERS
770Pseudomyxoma PeritoneiFAERS: 1US FAERS
771Pulmonary HypertensionFAERS: 1SIDER
US FAERS
772Pulmonary InfarctionFAERS: 1US FAERS
773Pulmonary function test decreasedFAERS: 1US FAERS
774Pulmonary necrosisFAERS: 1US FAERS
775Pulmonary thrombosisFAERS: 1US FAERS
776Puncture site swellingFAERS: 1US FAERS
777PurpuraFAERS: 1SIDER
US FAERS
778PyelitisFAERS: 1US FAERS
779Pyloric StenosisFAERS: 1US FAERS
780QuadriplegiaFAERS: 1US FAERS
781Renal cystFAERS: 1US FAERS
782Renal tubular acidosisFAERS: 1US FAERS
783Renal tubular disorderFAERS: 1US FAERS
784Renal tubular necrosisFAERS: 1US FAERS
785Renin decreasedFAERS: 1US FAERS
786Respiratory DepressionFAERS: 1US FAERS
787Respiratory arrestFAERS: 1US FAERS
788Respiratory rateFAERS: 1US FAERS
789Restless Legs SyndromeFAERS: 1SIDER
US FAERS
790Retinal Artery OcclusionFAERS: 1US FAERS
791Retinal DetachmentFAERS: 1US FAERS
792Retroperitoneal abscessFAERS: 1US FAERS
793RhabdomyolysisFAERS: 1SIDER
US FAERS
794RhabdomyosarcomaFAERS: 1US FAERS
795Right Ventricular HypertrophyFAERS: 1US FAERS
796Ruptured cerebral aneurysmFAERS: 1US FAERS
797SarcomaFAERS: 1US FAERS
798Scrotal massFAERS: 1US FAERS
799Semen volume decreasedFAERS: 1US FAERS
800Sensorimotor disorderFAERS: 1US FAERS
801Serous retinal detachmentFAERS: 1US FAERS
802Single functional kidneyFAERS: 1US FAERS
803Sinus rhythmFAERS: 1US FAERS
804Sjogren's SyndromeFAERS: 1US FAERS
805Skin hypertrophyFAERS: 1US FAERS
806Skin indentationFAERS: 1US FAERS
807Skin irritationFAERS: 1US FAERS
808Skin neoplasm excisionFAERS: 1US FAERS
809Small cell lung cancer extensive stageFAERS: 1US FAERS
810Sperm count decreasedFAERS: 1US FAERS
811Spinal shockFAERS: 1US FAERS
812Splenic InfarctionFAERS: 1US FAERS
813Splenic abscessFAERS: 1US FAERS
814Sputum retentionFAERS: 1US FAERS
815Squamous cell carcinomaFAERS: 1US FAERS
816Stevens-Johnson SyndromeFAERS: 1SIDER
US FAERS
817StressFAERS: 1OFFSIDES
US FAERS
818SubileusFAERS: 1US FAERS
819Sudden Visual LossFAERS: 1US FAERS
820Supraventricular tachyarrhythmiaFAERS: 1US FAERS
821Supraventricular tachycardiaFAERS: 1US FAERS
822SynovitisFAERS: 1US FAERS
823Systolic dysfunctionFAERS: 1US FAERS
824TachyarrhythmiaFAERS: 1US FAERS
825Teeth brittleFAERS: 1US FAERS
826Temperature intoleranceFAERS: 1OFFSIDES
US FAERS
827Terminal stateFAERS: 1US FAERS
828TetanyFAERS: 1US FAERS
829Therapeutic product ineffectiveFAERS: 1US FAERS
830Therapeutic response changedFAERS: 1US FAERS
831Therapy responderFAERS: 1US FAERS
832ThirstFAERS: 1US FAERS
833ThoracotomyFAERS: 1US FAERS
834ThrombophlebitisFAERS: 1US FAERS
835ThyroidectomyFAERS: 1US FAERS
836TinnitusFAERS: 1SIDER
US FAERS
837Tooth ErosionFAERS: 1US FAERS
838ToothacheFAERS: 1US FAERS
839Total cholesterol/HDL ratio increasedFAERS: 1US FAERS
840Toxic Epidermal NecrolysisFAERS: 1SIDER
US FAERS
841Toxic Shock SyndromeFAERS: 1US FAERS
842TransplantFAERS: 1US FAERS
843Traumatic fractureFAERS: 1US FAERS
844Troponin increasedFAERS: 1US FAERS
845Tumour haemorrhageFAERS: 1SIDER
US FAERS
846Typhoid FeverFAERS: 1US FAERS
847Ultrasound ovary abnormalFAERS: 1US FAERS
848UnderweightFAERS: 1US FAERS
849Unmasking of previously unidentified diseaseFAERS: 1US FAERS
850Unresponsive to stimuliFAERS: 1US FAERS
851Urinary RetentionFAERS: 1US FAERS
852Urinary tract obstructionFAERS: 1US FAERS
853Vascular ruptureFAERS: 1US FAERS
854Vascular stenosisFAERS: 1US FAERS
855Venoocclusive diseaseFAERS: 1US FAERS
856Venous ThrombosisFAERS: 1US FAERS
857Venous thrombosis limbFAERS: 1US FAERS
858Vertebrobasilar InsufficiencyFAERS: 1US FAERS
859Viral upper respiratory tract infectionFAERS: 1US FAERS
860Visual disturbanceFAERS: 1US FAERS
861Vital functions abnormalFAERS: 1US FAERS
862Vitamin D DeficiencyFAERS: 1US FAERS
863Wrong technique in device usage processFAERS: 1US FAERS
864XerophthalmiaFAERS: 1US FAERS
865ZygomycosisFAERS: 1US FAERS
866muscle injuryFAERS: 1US FAERS
867ovarian neoplasmFAERS: 1US FAERS
868prostatitisFAERS: 1US FAERS
869AmyloidosisOFFSIDES
870Anaphylactic shockSIDER
871Antidepressant drug clearance decreasedOFFSIDES
872AnuriaOFFSIDES
873ArthropathyOFFSIDES
874Biliary tract infectionOFFSIDES
875Bladder catheter temporaryOFFSIDES
876Blast cell count increasedOFFSIDES
877BlepharitisSIDER
878Blood GlucoseOFFSIDES
879Blood amylase increasedSIDER
880Blood and lymphatic system disordersSIDER
881Blood beta-D-glucan increasedOFFSIDES
882Blood chloride decreasedOFFSIDES
883Blood fibrinogenOFFSIDES
884Blood in stoolSIDER
885Blood magnesium decreasedOFFSIDES
886Blood potassiumOFFSIDES
887Blood sodiumOFFSIDES
888Blurred visionOFFSIDES
889BronchiectasisOFFSIDES
890Bullous eruptionSIDER
891CYTOMEGALOVIRUS ANTIGENOFFSIDES
892Cardioactive drug levelOFFSIDES
893Cell marker increasedOFFSIDES
894Cerebral disorderOFFSIDES
895Cerebrovascular InsufficiencyOFFSIDES
896Cerebrovascular operationOFFSIDES
897Cervical laser therapyOFFSIDES
898CheilitisSIDER
899Chest wall cystOFFSIDES
900Choking sensationOFFSIDES
901ChokingOFFSIDES
902CholangiolitisOFFSIDES
903ColectomyOFFSIDES
904Colon adenomaOFFSIDES
905Compression fractureOFFSIDES
906Conjunctival depositOFFSIDES
907Creatine Phosphokinase IncreasedSIDER
908Creatinine increasedSIDER
909Cytolytic hepatitisOFFSIDES
910DiarrheaOFFSIDES
911Disturbance in sexual arousalSIDER
912DiverticulitisSIDER
913Drug ToleranceOFFSIDES
914DyslaliaOFFSIDES
915Ear and labyrinth disordersSIDER
916Electrocardiogram ST-T segment abnormalOFFSIDES
917EncephalitisOFFSIDES
918Endoscopy gastrointestinal abnormalOFFSIDES
919Engraftment syndromeOFFSIDES
920Enterococcal infectionOFFSIDES
921Exploratory operationOFFSIDES
922Familial Mediterranean FeverOFFSIDES
923Fibrin D dimer decreasedOFFSIDES
924Fibrin decreasedOFFSIDES
925FolliculitisSIDER
926Gas GangreneOFFSIDES
927Gastric ulcerSIDER
928GastroenteritisSIDER
929Gastrointestinal mucosal exfoliationOFFSIDES
930Gastrointestinal obstructionSIDER
931GlaucomaSIDER
932Granulocyte count decreasedOFFSIDES
933HeartburnSIDER
934HepatectomyOFFSIDES
935Hepatitis B positiveOFFSIDES
936High frequency ablationOFFSIDES
937HypercapniaOFFSIDES
938Hypereosinophilic syndromeOFFSIDES
939HypotrichosisSIDER
940Ileal StenosisOFFSIDES
941Immunosuppressant drug level decreasedOFFSIDES
942Implant site infectionOFFSIDES
943Increased tendency to bruiseSIDER
944InfestationSIDER
945Injury asphyxiationOFFSIDES
946IntubationOFFSIDES
947Lactic dehydrogenase activity increasedSIDER
948Left Ventricular HypertrophyOFFSIDES
949Left ventricular end-diastolic pressure increasedOFFSIDES
950LeukodermaSIDER
951Leukopenia neonatalOFFSIDES
952LightheadednessSIDER
953MacrocytosisOFFSIDES
954MastocytosisSIDER
955Mechanical ventilationOFFSIDES
956Meningeal disorderOFFSIDES
957MenorrhagiaSIDER
958Mental status changesOFFSIDES
959Metamyelocyte count increasedOFFSIDES
960MucormycosisOFFSIDES
961Muscle WeaknessOFFSIDES
962Muscle necrosisOFFSIDES
963MyelosuppressionSIDER
964Nail pigmentationOFFSIDES
965NephrectomyOFFSIDES
966Nipple painSIDER
967Non-cardiac chest painOFFSIDES
968Oedema aggravatedSIDER
969Optic NeuropathyOFFSIDES
970Oral mucosal exfoliationOFFSIDES
971Oropharyngeal discomfortSIDER
972OsteopeniaOFFSIDES
973PanniculitisOFFSIDES
974Perirectal abscessOFFSIDES
975Pharyngeal MucositisSIDER
976Pharyngolaryngeal PainSIDER
977Platelet TransfusionOFFSIDES
978Pleuritic painSIDER
979PleurodesisOFFSIDES
980PolymyositisOFFSIDES
981Protein-losing gastroenteropathyOFFSIDES
982Prothrombin time abnormalOFFSIDES
983Pupillary light reflex tests abnormalOFFSIDES
984Reflux gastritisOFFSIDES
985RegurgitationOFFSIDES
986RhinitisSIDER
987SequestrectomyOFFSIDES
988Sexual DysfunctionSIDER
989Sigmoidoscopy abnormalOFFSIDES
990Skin carcinomaSIDER
991Squamous cell carcinoma of skinOFFSIDES
992Stenotrophomonas infectionOFFSIDES
993StridorOFFSIDES
994Subcutaneous EmphysemaOFFSIDES
995SweatingSIDER
996Therapeutic product effect decreasedCanada Vigilance: 1Canada Vigilance
997Therapeutic response unexpectedOFFSIDES
998Tooth ExtractionOFFSIDES
999Vascular purpuraSIDER
1000VasculitisSIDER
1001Waist circumference increasedOFFSIDES
1002Weight GainOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.